Delayed cytogenetic response with prolonged interferon-alpha treatment in chronic myeloid leukemia patients: quantification of BCR-ABL transcript by competitive reverse transcription-polymerase chain reaction

Haematologica. 2001 Oct;86(10):1101-3.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Cytogenetic Analysis
  • Female
  • Fusion Proteins, bcr-abl / genetics
  • Humans
  • Interferon-alpha / administration & dosage*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics
  • Male
  • Middle Aged
  • RNA, Messenger / analysis
  • Reverse Transcriptase Polymerase Chain Reaction
  • Treatment Outcome

Substances

  • Interferon-alpha
  • RNA, Messenger
  • Fusion Proteins, bcr-abl